257 related articles for article (PubMed ID: 26732432)
1. Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer's disease pathology.
Rosenberger AF; Morrema TH; Gerritsen WH; van Haastert ES; Snkhchyan H; Hilhorst R; Rozemuller AJ; Scheltens P; van der Vies SM; Hoozemans JJ
J Neuroinflammation; 2016 Jan; 13():4. PubMed ID: 26732432
[TBL] [Abstract][Full Text] [Related]
2. Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury.
Calingasan NY; Erdely HA; Altar CA
Neurobiol Aging; 2002; 23(1):31-9. PubMed ID: 11755016
[TBL] [Abstract][Full Text] [Related]
3. A Potential Role for α-Amylase in Amyloid-β-Induced Astrocytic Glycogenolysis and Activation.
Byman E; Schultz N; ; Blom AM; Wennström M
J Alzheimers Dis; 2019; 68(1):205-217. PubMed ID: 30775997
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
5. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β
Ebrahimi T; Rust M; Kaiser SN; Slowik A; Beyer C; Koczulla AR; Schulz JB; Habib P; Bach JP
J Neuroinflammation; 2018 Sep; 15(1):282. PubMed ID: 30261895
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CK2 mitigates Alzheimer's tau pathology by preventing NR2B synaptic mislocalization.
Marshall CA; McBride JD; Changolkar L; Riddle DM; Trojanowski JQ; Lee VM
Acta Neuropathol Commun; 2022 Mar; 10(1):30. PubMed ID: 35246269
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory pathology markers (activated microglia and reactive astrocytes) in early and late onset Alzheimer disease: a post mortem study.
Taipa R; Ferreira V; Brochado P; Robinson A; Reis I; Marques F; Mann DM; Melo-Pires M; Sousa N
Neuropathol Appl Neurobiol; 2018 Apr; 44(3):298-313. PubMed ID: 29044639
[TBL] [Abstract][Full Text] [Related]
9. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
[TBL] [Abstract][Full Text] [Related]
10. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.
Sheng JG; Mrak RE; Griffin WS
Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of phosphorylated translation initiation factor 2 alpha in Alzheimer's disease and Creutzfeldt-Jakob's disease.
Ferrer I
Neuropathol Appl Neurobiol; 2002 Dec; 28(6):441-51. PubMed ID: 12445160
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel PET ligand, [
Ogata A; Yamada T; Hattori S; Ikenuma H; Abe J; Tada M; Ichise M; Suzuki M; Ito K; Kato T; Amaike K; Hirota T; Kakita A; Itami K; Kimura Y
Bioorg Med Chem Lett; 2023 Jun; 90():129327. PubMed ID: 37187253
[TBL] [Abstract][Full Text] [Related]
13. Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model.
Ghosh S; Wu MD; Shaftel SS; Kyrkanides S; LaFerla FM; Olschowka JA; O'Banion MK
J Neurosci; 2013 Mar; 33(11):5053-64. PubMed ID: 23486975
[TBL] [Abstract][Full Text] [Related]
14. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
Darreh-Shori T; Vijayaraghavan S; Aeinehband S; Piehl F; Lindblom RP; Nilsson B; Ekdahl KN; Långström B; Almkvist O; Nordberg A
Neurobiol Aging; 2013 Nov; 34(11):2465-81. PubMed ID: 23759148
[TBL] [Abstract][Full Text] [Related]
15. Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.
Li L; Xu S; Liu L; Feng R; Gong Y; Zhao X; Li J; Cai J; Feng N; Wang L; Wang X; Peng Y
J Alzheimers Dis; 2017; 56(4):1403-1417. PubMed ID: 28157092
[TBL] [Abstract][Full Text] [Related]
16. Effects of methylmercury on the secretion of pro-inflammatory cytokines from primary microglial cells and astrocytes.
Bassett T; Bach P; Chan HM
Neurotoxicology; 2012 Mar; 33(2):229-34. PubMed ID: 22037494
[TBL] [Abstract][Full Text] [Related]
17. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.
Barroeta-Espar I; Weinstock LD; Perez-Nievas BG; Meltzer AC; Siao Tick Chong M; Amaral AC; Murray ME; Moulder KL; Morris JC; Cairns NJ; Parisi JE; Lowe VJ; Petersen RC; Kofler J; Ikonomovic MD; López O; Klunk WE; Mayeux RP; Frosch MP; Wood LB; Gomez-Isla T
Neurobiol Dis; 2019 Jan; 121():327-337. PubMed ID: 30336198
[TBL] [Abstract][Full Text] [Related]
18. Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease.
Ting KK; Brew BJ; Guillemin GJ
J Neuroinflammation; 2009 Dec; 6():36. PubMed ID: 20003262
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid a differentially activates microglia and astrocytes via the PI3K pathway.
Yu Y; Liu J; Li SQ; Peng L; Ye RD
J Alzheimers Dis; 2014; 38(1):133-44. PubMed ID: 23948927
[TBL] [Abstract][Full Text] [Related]
20. Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease.
Kamphuis W; Middeldorp J; Kooijman L; Sluijs JA; Kooi EJ; Moeton M; Freriks M; Mizee MR; Hol EM
Neurobiol Aging; 2014 Mar; 35(3):492-510. PubMed ID: 24269023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
